1. Home
  2. MNDR vs BIAF Comparison

MNDR vs BIAF Comparison

Compare MNDR & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • BIAF
  • Stock Information
  • Founded
  • MNDR 2016
  • BIAF 2014
  • Country
  • MNDR Singapore
  • BIAF United States
  • Employees
  • MNDR N/A
  • BIAF N/A
  • Industry
  • MNDR
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MNDR
  • BIAF Health Care
  • Exchange
  • MNDR Nasdaq
  • BIAF Nasdaq
  • Market Cap
  • MNDR 10.1M
  • BIAF 11.1M
  • IPO Year
  • MNDR 2024
  • BIAF 2022
  • Fundamental
  • Price
  • MNDR $0.28
  • BIAF $0.73
  • Analyst Decision
  • MNDR
  • BIAF Strong Buy
  • Analyst Count
  • MNDR 0
  • BIAF 1
  • Target Price
  • MNDR N/A
  • BIAF $6.00
  • AVG Volume (30 Days)
  • MNDR 1.7M
  • BIAF 300.4K
  • Earning Date
  • MNDR 10-29-2024
  • BIAF 03-31-2025
  • Dividend Yield
  • MNDR N/A
  • BIAF N/A
  • EPS Growth
  • MNDR N/A
  • BIAF N/A
  • EPS
  • MNDR N/A
  • BIAF N/A
  • Revenue
  • MNDR $13,968,535.00
  • BIAF $9,367,785.00
  • Revenue This Year
  • MNDR $188,831.77
  • BIAF $285.51
  • Revenue Next Year
  • MNDR $76.44
  • BIAF $20.05
  • P/E Ratio
  • MNDR N/A
  • BIAF N/A
  • Revenue Growth
  • MNDR 77.38
  • BIAF 2813.87
  • 52 Week Low
  • MNDR $0.23
  • BIAF $0.57
  • 52 Week High
  • MNDR $29.50
  • BIAF $3.62
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • BIAF 37.84
  • Support Level
  • MNDR N/A
  • BIAF $0.69
  • Resistance Level
  • MNDR N/A
  • BIAF $0.85
  • Average True Range (ATR)
  • MNDR 0.00
  • BIAF 0.08
  • MACD
  • MNDR 0.00
  • BIAF 0.01
  • Stochastic Oscillator
  • MNDR 0.00
  • BIAF 50.00

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: